Global Healthcare Study on Psoriasis (GHSP): cohort profile and first findings

By afschroeder • May 20, 2026

Maul JT, Fröhlich F, Nielsen ML, Maul LV, Torres T, Thyssen J, Armstrong A, Oon HH, Ji M, Kang X, Valenzuela F, Romiti R, Carvalho AVE, Novoa F, Sousa M, Luz M, Guevara BEK, Doss N, Gisondi P, Chularojanamontri L, Kündig TM, Egeberg A, Thomsen SF, Didaskalu JA. Global Healthcare Study on Psoriasis (GHSP): cohort profile and first findings. BMJ Open. 2026 May 19;16(5):e112891. doi: 10.1136/bmjopen-2025-112891. PMID: 42156142.

Tags: Adult dermatology, Dermatological epidemiology, Dermatology, psoriasis, Publications

Related Posts

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial

Elbuluk N, Armstrong AW, Vender R, Bhutani T, Green L, Ferris LK, Laquer V, Moore A, Weisman J, Zhang W, Winkelman W, Gooderham MJ. Zasocitinib[...]

Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial

Lebwohl M, Blauvelt A, Kartman CE, Leatherwood C, Gordon KB, Sattar N, Puig L, Merola JF, Siu K, Wang R, Sun L, Leung A, Somani[...]

Use of ancillary studies in pediatric spitzoid neoplasms: A retrospective cohort study

Chen A, Krenitsky A, Perry SS, Tan KW, Swick BL, Anderson KR, Barry KK, Kelsey B, Carlberg VM, Coughlin CC, Craddock M, Fadzeyeva H, Ferringer[...]